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The gene for pilin, the monomeric protein subunit from which the pilus of Bacteroides nodosus is 
constructed, has been isolated. Isolation was achieved by cloning the fragmented genome of B. nodosus 
in Escherichia coli RR1 using the plasmid vector pBR322. Pilin-producing colonies were identified by 
screening with a colony immunoassay using antiserum from a sheep immunized against purified pili from 
B. nodosus strain 198, and were further characterized by immunoblot analysis. Final confirmation of the 
presence of the pilin gene was by nucleotide sequence data which translated to the known pilin amino acid 
sequence. 
Pilin Bacteroides nodosus 
1. INTRODUCTION 
Pili are filamentous surface appendages occur- 
ring in many genera of Gram-negative bacteria. 
Bacterial species as diverse as Neisseria gonor- 
rhoeae, Pseudomonas aeruginosa, Moraxella 
nonliquefaciens and Bacteroides nodosus, show a 
high degree of similarity in pilus structure [l-4]. 
Each pilus is composed of identical monomeric 
subunits of the protein pilin of A4, - 18000, the 
NH*-terminal amino acid sequence of which is 
highly conserved between the genera. Vaccines 
prepared from purified pili have been shown to 
provide prophylaxis against infection. In the case 
of N. gonorrhoeae, human volunteers were pro- 
tected against gonorrhoea from urethral challenge 
[5], while sheep vaccinated with pili from B. 
nodosus were protected against infection with 
footrot incurred from strains of the homologous 
serogroup [6-S]. 
Current commercial vaccines against footrot 
contain piliated bacteria from each of 8 major 
Abbreviations: PAGE, polyacrylamide gel elec- 
trophoresis; kbp, kilobase pair 
Footrot Cloning 
serogroups of B. nodosus [9]. This vaccine is 
relatively expensive due to the inclusion of such a 
large number of serogroups of B. nodosus, as well 
as the fastidious growth requirements, relatively 
sparse growth and variable pilus expression of this 
anaerobe when grown in bulk liquid culture. As an 
approach to reduce the cost of vaccination we are 
attempting to produce the pilin protein by recom- 
binant DNA techniques. This paper reports the 
isolation, by cloning, of the gene encoding the pilin 
protein of B. nodosus strain 198. 
2. EXPERIMENTAL 
2.1. Preparation of DNA from B. nodosus 
B. nodosus (strain 198) was harvested from 
modified Eugon broth [9] after anaerobic growth 
for up to 2 days at 37°C. Cells from a l-l culture 
were washed in 0.15 M NaCI, 0.1 M EDTA (pH 
8.0), and resuspended in 4 ml of 25% sucrose in 
50 mM Tris-Cl, 10 mM EDTA (pH 8.0). 
Lysozyme (1 ml of 10 mg/ml), EDTA (1.25 ml of 
0.25 M, pH 8.0) and ribonuclease (66~1 of 
10 mg/ml, heat-treated) were added with incuba- 
tion of 0°C for 30 min. Proteinase K (1 mg) was 
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added, and cell lysis was brought about by the 
rapid addition with mixing of SDS (2 ml of 2%). 
After 15 min at O”C, the mixture was incubated 
overnight at 37°C. The lysate was extracted for 
40 min at 0°C with an equal volume of neutralized 
phenol by rotating the emulsion at 60 rpm. To the 
separated aqueous phase, two vols ethanol at 
- 20°C were gently added; DNA was removed by 
spooling as it precipitated at the interface. The 
precipitate was washed in 70% ethanol, air-dried, 
and dissolved in 1 ml of 10 mM Tris-Cl, 1 mM 
EDTA (pH 8.0). The DNA preparation was band- 
ed in CsCl/ethidium bromide by equilibrium den- 
sity gradient centrifugation [lo]. 
2.2. Construction of a clone bank from 
B. nodosus 
DNA was digested for 1 h with sufficient 
Sau3AI to produce the maximum number of 
10 kbp fragments as judged by electrophoresis on 
1% agarose gel. To ensure a representative 
distribution of the genome within this size range, 
digestion times of 1 and 2 h were also used and the 
total mixture was size-fractionated on a lo-40% 
neutral sucrose gradient for fragment sizes of 
7-15 kbp [ll]. 
DNA fragments (15 pug/ml) were ligated to 
BamHI-cleaved, dephosphorylated pBR322 (5 pg/ 
ml) and the mixture was used to transform E. coli 
strain RR1 [12]. Recombinant clones sensitive to 
tetracycline were grown to saturation in the 
presence of 50 pg/ml ampicillin in individual wells 
of microtitre plates in a medium which permitted 
free storage of cells without further additions [ 131. 
These cultures were stored frozen at -70°C and 
could be thawed and refrozen several times. Ap- 
prox. 1500 colonies were screened by the 
immunoassay. 
2.3. Screening of recombinant clones 
Colonies grown overnight on YT agar plates [ 141 
containing 50 pg/ml ampicillin were transferred by 
‘lifting’ to nitrocellulose filters. Following cell lysis 
[15] colonies were screened for the presence of 
pilin by sheep IgGl anti-pili (strain 198) antiserum, 
followed by rabbit IgG anti-sheep IgG antiserum 
(Nordic, Tilburg, The Netherlands) and finally 
10 &i 1251-labelled protein A from S. aureus 
(Amersham). Positive clones from this assay were 
further analysed by immunoblotting [16]. These 
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clones together with a pili standard from B. nodo- 
sus strain 198 were subjected to SDS-PAGE in 
12.5% acrylamide under reducing conditions using 
the discontinuous buffer system in [17]. Proteins 
were electrophoretically transferred to nitrocellu- 
lose and the membrane probed with the antisera 
described above. 
2.4. Preparation of plasmids from E. coli 
Plasmids were prepared from clone bank 
cultures grown to saturation overnight in YT 
media containing 50 /cg/ml ampicillin. Harvested 
cells were resuspended in 25% sucrose (3% of the 
growth volume), and lysozyme-EDTA sphero- 
plasts were prepared [18]. Cell lysis was accom- 
plished by an equal volume of 0.1% Triton X-100. 
Plasmid was isolated from the cleared lysate either 
by CsCl/ethidium bromide equilibrium density 
gradient centrifugation [ 111, or by phenol extrac- 
tion followed by 3 ethanol precipitations [19] - 
the second precipitation in the presence of ammo- 
nium acetate [20] to improve restriction of the 
DNA. 
2.5. Subcloning and nucleic acid sequence 
determination 
Restriction endonuclease digests of plasmids 
were fractionated by electrophoresis in submerged, 
horizontal agarose gels (1% agarose in 0.04 M 
Tris-acetate buffer (pH 8.3) containing 20 mM 
sodium acetate, 1.0 mM EDTA and 0.5 pg/ml 
ethidium bromide). Fragment sizes were deter- 
mined relative to a HindIII/EcoRI digest of 
phage A. 
DNA was isolated from the gel by elec- 
trophoresis onto DEAE membrane slotted in front 
of the band [21]. Fragments were ligated into 
pBR322 and used to transform E. coli strain RR1 . 
Certain fragments containing sufficient pBR322 
vector for replication and antibiotic selection were 
self-ligated. For sequence studies fragments were 
ligated into M13mp8 [22] to prepare single- 
stranded template for the dideoxy chain- 
termination method of sequence determination 
]231. 
2.6. Fractionation of cellular components of 
E. coli 
The cellular location of pilin expressed in E. coli 
was determined by separating the cellular com- 
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ponents into periplasmic, cytoplasmic and mem- 
brane fractions [24]. Lysozyme-EDTA sphero- 
plasts were prepared and lysed by osmotic shock. 
The membrane pellet was further fractionated by 
equilibrium density gradient centrifugation in 
30-50% sucrose. Separated cellular components 
were assayed for pilin by immunoblotting. 
3. RESULTS 
DNA prepared from B. nodosus strain 198 
showed only a single band of linear chromosomal 
DNA in CsCl/ethidium bromide gradients. Screen- 
ing of 1500 colonies from the clone bank prepared 
from this DNA yielded 12 positive clones as judged 
by the colony immunoassay. Eight produced a pro- 
tein product which had an electrophoretic mobility 
corresponding to pilin on immunoblotting, while 
the other 4 produced proteins of a lower Mr. The 
recombinant plasmids from the probable pilin- 
producing colonies were analysed by restriction en- 
donuclease digestion (HindIII, EcoRI, BarnHI and 
PstI in various combinations) and were found to 
produce band patterns having several bands in 
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common. Analysis of the restriction maps deduced 
from these digestions (fig.1) indicated a common 
region of 6.5 kbp in the inserts. This region was 
present in both orientations relative to pBR322 
vector. 
Clone 7Al (fig.1) was selected for further study 
because of a favourable distribution of restriction 
sites relative to the pBR322 vector. Plasmid 
isolated from clone 7Al was cleaved by Hind111 or 
EcoRI digestion. The largest fragment of either 
digest still contained the origin of replication and 
,&lactamase gene of pBR322. Recircularisation of 
these fragments produced a plasmid which still 
transformed E. coli to pilin production. The 
plasmid derived from clone 7Al by EcoRI diges- 
tion contained only a 2.9 kbp insert in pBR322 (see 
clone 7AlE of fig.1). Further subcloning of this 
region by isolation of the 1.8 kbp PstI/EcoRI 
fragment and its insertion into pBR322 in place of 
the smaller PstI/EcoRI fragment of this vector 
produced a plasmid which failed to transform E. 
coli to pilin production (see clone 7AlE/P of 
fig.1). This same 1.8 kbp fragment was ‘force 
cloned’ into M13mp8 for sequence determination. 
A 
7&d 7AIE ,AIE,P 
Fig. 1. (A) Restriction endonuclease cl avage maps of plasmids prepared from 6 pilin-producing clones of E. coli (7A1, 
12D5, 9H3, 16H2, 8F12, 5A5). The fragmented genome of B. nodows was cloned into the BanzHI site (B’) of pBR322 
vector. The ‘arms’ of the pBR322 vector are shown outside the brackets. The restriction sites marked are EcoRI(E), 
BumHI( HindIII(H) and PstI(P). The insert region (2.9 kbp) of the plasmid from a pilin-producing subclone derived 
from clone 7Al is also shown (+-- b). The small arrow indicates both the length of the coding sequence for mature 
pilin protein and the direction of transcription. (B) Plasmid from clone 7Al together with plasmids from subclones 
7AlE and 7AlE/P. Insert regions are drawn to half-scale relative to pBR322 vector. 
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Sequence information confirmed that the coded 
product was pilin (fig.2), and that PstI cuts within 
the coding sequence of the pilin gene. 
Preliminary studies on the cellular location of 
the pilin produced by E. coli revealed that it is ab- 
sent from the supernatant, the periplasmic space 
and the cytoplasm, the fractionates on sucrose 
density gradients with the membranous prepara- 
tions . 
4. DISCUSSION 
The pilin gene of B. nodosus strain 198 has been 
cloned and expressed in E. coli. The expression of 
the gene when inserted in either orientation into 
the BamHI site of pBR322 indicated that expres- 
sion was from a cloned B. nodosus promoter. 
Subclones from clone 7A1, retaining the ability to 
express pilin, localised the gene to a 2.9 kbp frag- 
ment of DNA (fig. 1). A nucleotide sequence which 
translated to the known pilin amino acid sequence 
[4] was found within this fragment, so confirming 
the presence of the pilin gene and pinpointing the 
coding region. Thus the GCA sequence of the 
single PstI site (CTGCAG) within the plasmid in- 
sert of clone 7Al codes for alanine residue 108 of 
the mature pilin protein, and the presence of 
coding sequence for the C-terminus of the protein 
within the 1.8 kbp PstI/EcoRI fragment (fig.2) in- 
dicates that transcription must proceed down- 
stream towards the single EcoRI site of the insert. 
The gene for pilin production is, then, located in 
the B. nodosus genome of strain 198 between two 
Hind111 sites 5.5 kbp apart and within the bounds 
of a 3.7 kbp HindIII-EcoRI fragment. A single 
PstI site in the centre of this 3.7 kbp fragment is 
located within the protein coding sequence. Ex- 
pression of pilin from the coding sequence depends 
on a sequence less than 1 .l kbp upstream of this 
PstI site from a promoter recognized by the RNA 
polymerase of E. coli. 
The production of pilin from B. nodosus by a 
host having less fastidious growth requirements 
provides encouragement for the development of a 
‘recombinant DNA’-produced vaccine to replace 
the conventional whole-cell B. nodosus vaccine. 
The latter is both expensive to manufacture, and 
causes vaccinal lesions at the site of inoculation 
through administration of a large amount of ex- 
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Fig.2. Autoradiograph of a portion of a sequencing el 
for the 1.8 kbp PsWEcoRI fragment cloned into 
M13mp8. The sequence is read from the PstI site 
towards the EcoRI site in the direction indicated by the 
arrow. The amino acid sequence corresponding to the 
nucleic acid sequence data is shown, together with the 
positions of these amino acid residues in the pilin 
sequence. 
traneous antigen in the oil adjuvant [25]. A recom- 
binant DNA-produced vaccine could lower 
manufacturing costs, reduce vaccination reactions, 
and circumvent the problem of variable pilus ex- 
pression in bulk liquid culture. 
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